Manufacturers Life Insurance Company, The Vertex Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 545,366 shares of VRTX stock, worth $274 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
545,366
Previous 622,225
12.35%
Holding current value
$274 Million
Previous $289 Million
24.11%
% of portfolio
0.2%
Previous 0.27%
Shares
34 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
228MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.3 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.7 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.7 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.03 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.25 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $129B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...